Amy Sullivan, PsyD


Amy Sullivan, PsyD: Personalized Approach to Fatigue in Multiple Sclerosis

The Director of Behavioral Medicine at the Mellen Center for MS Treatment and Research at the Cleveland Clinic spoke about how she approaches fatigue in MS from a behavioral standpoint.

Jeff Waugh, MD, PhD


Jeff Waugh, MD, PhD: Viewing Striatal Injury More Granularly

Despite some mistrusting the abilities of imaging to aid in therapeutic development, a new MRI method could better inform the anatomical understanding of the striatum.

Patricia K. Coyle, MD


Ofatumumab and the Anti-CD20 Class

An expert discusses takeaways about the anti-CD20 monoclonal antibody class of disease-modifying therapies for patients with relapsing multiple sclerosis through the lens of ofatumumab (Kesimpta; Novartis).

Dominic Pelle, MD


Dominic Pelle, MD: Improving Patient-Reported Outcomes in Spine Surgery

The spine surgeon in the Center for Spine Health at Cleveland Clinic spoke to the importance of improving patient-reported outcomes and ensuring consistent communication with patients undergoing spine surgery.

James Leverenz, MD


Current and Future Landscape of Alzheimer Disease Treatment: Emergence of Disease Modifying Therapies

After years of failed drug development, the thoughts of disease-modifying therapies for Alzheimer disease are starting to become real.

Jerrold L. Vitek, MD, PhD


Jerrold L. Vitek, MD, PhD: Multiple Independent Contact Current-Controlled DBS Technology

The professor and head of the department of neurology at the University of Minnesota discussed what multiple independent contact current-controlled devices offer physicians conducting deep brain stimulation.

Mia Minen, MD, MPH


Mia Minen, MD, MPH: Behavioral Therapies for Posttraumatic Headache

Mia Minen, MD, MPH, sat down for an interview to discuss why behavioral therapies could be an effective and easily accessible treatment for posttraumatic headaches following events like concussions.

Eugenia Trushina, PhD


Eugenia Trushina, PhD: Communication and Learning Through Collaboration

For the associate professor of neurology, learning, listening, and collaborating are the keys to improving the field of care.

Chia-Chun Chiang, MD


Chia-Chun Chiang, MD: Collecting Real-World Data Following FDA Approvals

The neurologist at Mayo Clinic in Phoenix, Arizona, detailed the importance of further studies of FDA approved medications in different patient populations.

Ronald C. Petersen, MD, PhD


The Potential of Blood Tests to Improve Screening and Monitoring in Alzheimer Disease Clinical Trials: Ronald C. Petersen, MD, PhD

The director of the Alzheimer’s Disease Research Center at Mayo Clinic detailed the current issues with access and affordability to critical biomarkers in the screening and monitoring of patients in Alzheimer disease trials. [WATCH TIME: 3 minutes]

David K. B. Li, MD, FRCPC


The Importance of a Globally Aligned, Standardized MRI Protocol for MS

Leaders of the CMSC Working Group on MRI protocols and clinical guidelines express the need for a unified approach to diagnosing and monitoring multiple sclerosis.

Clive Ballard, MD


Pimavanserin Safety Data and Future Research: Clive Ballard, MD

Clive Ballard, MD, spoke on the safety data of pimavanserin, which was presented at the 2021 AAIC meeting, held from July 26-30.

Ari Green, MD, MCR


Ari Green, MD, MCR: Remyelination in Multiple Sclerosis

The medical director of the UCSF Multiple Sclerosis Center discussed the idea behind remyelination and shared his thoughts on what the best shot at developing a therapy might be.

Danielle Andrade, MD, MSc


Rare Epilepsies, Comorbidities, and Genetic Therapies: Danielle Andrade, MD, MSc, FRCPC

The professor of neurology at the University of Toronto talked about 3 conditions that were discussed during the epilepsy therapies symposium at the 2022 AES Conference. [WATCH TIME: 5 minutes]

Deborah Friedman, MD, MPH


Deborah Friedman, MD, MPH: Coordinating Care in Telemedicine

The professor of neurology, neurotherapeutics, and ophthalmology at UT Southwestern discussed the need to better coordinate care between providers when telemedicine is being utilized in headache and migraine care.

Trevor Dyson-Hudson, MD


Trevor Dyson-Hudson, MD: Unseen Consequences of Spinal Cord Injury

The director of the Center for Spinal Cord Injury Research and co-director of the Spinal Cord Injury Model System Center at Kessler Foundation discussed the secondary medical complications of spinal cord injury and how he and colleagues seek to alleviate them.

Aaron Boster, MD


Treating MS: A Simplified Strategy Boosts Patient and Provider Satisfaction

Both the busy clinician and the overwhelmed patient benefit from a pointed approach to disease management.

Amit Bar-Or, MD, FRCPC


Novel and Emerging Targets in Multiple Sclerosis

Experts in neurology share their hopes for the future of multiple sclerosis treatment and discuss unmet needs and novel targets.

Paul Newhouse, MD


Paul Newhouse, MD: Muscarinic Agonists in Alzheimer Treatment

The Jim Turner Chair in Cognitive Disorders at the Vanderbilt University School of Medicine shared how the previous muscarinic agonists have better informed the development of this investigational agent, VU319.

Kenneth Bender, PharmD, MA


The “Grave Threat” Posed by the Shortage of Neurologists

With the physician deficit projected to grow larger within a decade, this global challenge has become a major focus of large organizations and medical societies.

Peii Chen, PhD


Peii Chen, PhD: Addressing Spatial Neglect After Stroke

The senior research scientist at Kessler Foundation offered her personal experience in treating spatial neglect in patients with stroke and potential future treatments on the way.

NeurologyLive® Staff


This Week on NeurologyLive® — March 27, 2023

Here's some of what is coming soon to NeurologyLive® this week.

John Corboy, MD


John Corboy, MD: The DISCO-MS Trial

The professor of neurology at Colorado University spoke about the ongoing phase IV trial to determine the safety of DMT discontinuation in MS.

© 2023 MJH Life Sciences

All rights reserved.